We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT (PPRA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01594814
First Posted: May 9, 2012
Last Update Posted: December 15, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland
May 8, 2012
May 9, 2012
December 15, 2014
January 2012
November 2014   (Final data collection date for primary outcome measure)
Health-related quality of life (HRQOL) [ Time Frame: two months ]
Mean score of Patient Perception of Arrhythmia Questionnaire (PPAQ) - a disease-specific QoL questionnaire for patients suffering from supraventricular tachycardia translated and validated according to ISPOR (International Society For Pharmacoeconomics and Outcomes Research) guidelines
Same as current
Complete list of historical versions of study NCT01594814 on ClinicalTrials.gov Archive Site
  • Utility of health state [ Time Frame: two months ]
    Mean score of EQ-5D - a generic questionnaire measuring a health state utility (official Polish translation)
  • Medical and indirect cost [ Time Frame: one year ]
    Cross-sectional data gathered using original questionnaire designed to measure medical and indiresct costs related to arrhythmia incurred during a year preceding RFA
  • Willingness-to-pay [ Time Frame: one day ]
    a cross-sectional willingness-to-pay questionnaire studying hypothetical situation where RFA was not financed by Polish Health Fund
  • Effectiveness [ Time Frame: two days ]
    Data on medical history, final diagnosis, outcome of treatment, safety and future recommendations
Same as current
Not Provided
Not Provided
 
Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT
Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT - a Quality of Life, Utility and Willingness to Pay Study (PPRA Study)

Atrioventricular nodal reciprocating tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT) are two similar supraventricular re-entry tachycardias (SVT) emerging in relatively young age in patients without apparent structural heart disease or significant comorbidities. The treatment of choice in those patients is radiofrequency ablation (RFA).

The PPRA study is a prospective observational study developed to thoroughly analyze quality of life, utility and willingness-to-pay of Polish patients undergoing RF ablation of AVNRT or AVRT.

Based on collected data the investigators will prepare a profile of patient who will benefit most from radiofrequency ablation and who should be scheduled in first place for the ablation in case of problems with accessibility to this service.

What is more an analysis of medical and indirect costs of care will be performed.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
All patients scheduled for ablation of AVNRT, AVRT or SVT will be eligible for the study.
  • Tachycardia, Atrioventricular Nodal Reentry
  • Re-entrant Atrioventricular Tachycardia
Procedure: RFA
radiofrequency ablation of slow pathway or accesory pathway
RFA of AVNRT of AVRT
Intervention: Procedure: RFA

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
82
November 2014
November 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Written informed consent
  2. Age above 18
  3. Scheduled RFA due to AVNRT or AVRT
  4. Sufficient knowledge of the Polish language to independently complete the questionnaires

Exclusion Criteria:

  1. No written informed consent
  2. Health states significantly impairing QoL (eg. stroke, advanced heart failure)
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Poland
 
 
NCT01594814
PPRA
Yes
Not Provided
Not Provided
Institute of Cardiology, Warsaw, Poland
Institute of Cardiology, Warsaw, Poland
Not Provided
Study Chair: Mariusz Pytkowski, MD, PhD Institute of Cardiology, Warsaw, Poland
Principal Investigator: Michal M Farkowski, MD Institute of Cardiology, Warsaw, Poland
Institute of Cardiology, Warsaw, Poland
December 2014